Wednesday, November 20, 2013
Print Current Session:
|
|
Wednesday
SESSION 26:
CRITICAL EVALUATION OF CAROTID TREATMENT – ACUTE STROKES AND CAROTID ARTERY STENTING (CAS) AS OF NOVEMBER 2013: WHERE ARE THEY GOING
Moderators:Thomas S. Riles, MD / Frank J. Veith, MD
|
|
SESSION 26 SCHEDULE | |
STATUS OF ACUTE STROKE TREATMENT | |
1:54 PM - 1:59 PM | How Well Are The New Endovascular Devices Working For Treatment Of Acute Strokes: Why The Negative Results Of The Recent Trials (MR RESCUE, IMS And SYNTHESIS XP) With The Solitaire, Trevo, Merci And Penumbra Devices May Not Be The Last Word |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
2:00 PM - 2:05 PM | Who Could (And Should) Perform Acute Stroke Interventions |
Presenter(s):Horst Sievert, MD | |
2:06 PM - 2:11 PM | Update On Endovascular Techniques And Results Of Carotid And Cerebral Artery Thrombectomy For Acute Strokes: How It Can Be Done Safely And Effectively And What Is The Risk: Experience In >150 Patients |
Presenter(s):Klaus D. Mathias, MD | |
STATUS OF CAROTID ARTERY STENTING (CAS) | |
2:12 PM - 2:17 PM | Improved Technology For CAS Will Improve CAS Outcomes: Why Membrane/Mesh Covered Stents And Flow Reversal Will Make A Difference: What Is Their Status |
Presenter(s):Claudio J. Schonholz, MD | |
2:18 PM - 2:23 PM | DEBATE: CREST Justifies Increased Usage Of CAS For Symptomatic And Asymptomatic Patients With Carotid Stenosis |
Presenter(s):William A. Gray, MD | |
2:24 PM - 2:29 PM | DEBATE: Nonsense: CREST Does Not Justify Increased Usage Of CAS For Symptomatic And Asymptomatic Carotid Stenosis |
Presenter(s):Michel Makaroun, MD | |
2:30 PM - 2:35 PM | What Is The Real Meaning Of Minor Strokes As Defined In CREST: Do They Matter More Than A Minor MI |
Presenter(s):Emmanuel M. Houdart, MD | |
2:36 PM - 2:41 PM | DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CEA Is Best And Does Not Increase Procedural Risk |
Presenter(s):A. Ross Naylor, MD, FRCS | |
2:42 PM - 2:47 PM | DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CAS Is Best And Can Be Done Safely |
Presenter(s):Barry T. Katzen, MD | |
2:48 PM - 2:53 PM | What Is The Best Current Treatment For Recently Symptomatic Carotid Stenosis: CAS Or CEA: Based On Combined Data From RCTs |
Presenter(s):Gustav Fraedrich, MD | |
ASYMPTOMATIC CAROTID STENOSIS | |
2:54 PM - 2:59 PM | DEBATE: Few If Any Patients Benefit From CEA Or CAS For Asymptomatic Carotid Stenosis In The Properly Used Statin Era |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
3:00 PM - 3:05 PM | DEBATE: Not So! Many Asymptomatic Carotid Stenosis Patients Benefit From CAS And CEA: Which Ones |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
3:06 PM - 3:11 PM | Asymptomatic Carotid Stenosis Can Progress And Become Symptomatic In A Substantial Proportion Of Patients |
Presenter(s):Richard P. Cambria, MD / Glenn M. LaMuraglia, MD / Mark Conrad, MD | |
3:12 PM - 3:17 PM | New Insights Into Selecting Asymptomatic Carotid Stenosis Patients At High Stroke Risk Who Should Have CAS Or CEA: The Importance Of Juxtaluminal Black Areas (JBAs) |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
View Abstract | |
3:18 PM - 3:23 PM | How To Pick High Risk Asymptomatic Carotid Stenosis Patients For CAS Or CEA: The Importance Of Transcranial Doppler Hits |
Presenter(s):J. David Spence, MD | |
View Abstract | |
3:24 PM - 3:29 PM | How To Pick Asymptomatic Carotid Stenosis Patients For CAS: What Percentage Of All Asymptomatic High Grade Lesions Should Be Treated |
Presenter(s):Sriram S. Iyer, MD | |
3:30 PM - 3:40 PM | Panel Discussion |
3:40 PM - 4:00 PM | Break - 40th Anniversary Celebration (Cocktails Will Be Served)Rhinelander Gallery (2nd Floor) |
END OF SESSION 26 | |
previous | next |